Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

NCT06712888 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

466

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: TORIPALIMAB INJECTION (JS001 ) combine with GP chemotherapy
DRUG: GP plus placebo induction therapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]